Marshall Wace North America’s VEON VEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-41,689
Closed -$2.18M 1637
2019
Q1
$2.18M Buy
41,689
+40,284
+2,867% +$2.51M 0.02% 484
2018
Q4
$83K Buy
1,405
+973
+225% +$65.7K ﹤0.01% 1124
2018
Q3
$31K Buy
+432
New +$31.3K ﹤0.01% 884
2018
Q1
Sell
-16,236
Closed -$1.56M 1717
2017
Q4
$1.56M Buy
16,236
+15,062
+1,283% +$1.47M 0.01% 901
2017
Q3
$117K Sell
1,174
-62,093
-98% -$6.34M ﹤0.01% 1201
2017
Q2
$6.33M Buy
63,267
+54,291
+605% +$5.35M 0.05% 431
2017
Q1
$898K Buy
+8,976
New +$922K 0.01% 719

Other funds holding VEON

Marshall Wace North America's VEON Position: Q2 2019 in Review

Marshall Wace North America sold out of VEON (VEON) in Q2 2019, closing a stake of 41,689 shares — an estimated $2.18M sold.

Marshall Wace North America first reported a position in VEON in Q1 2017 and held it in 7 quarters. The position peaked at $6.33M in Q2 2017. 117 funds tracked by Wall St. Rank hold VEON as of Q2 2019.

  • Marshall Wace North America reported no remaining VEON position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace North America sold 41,689 VEON shares in Q2 2019, an estimated $2.18M.
  • Marshall Wace North America first reported a position in VEON in Q1 2017 and held it in 7 quarters.
  • Marshall Wace North America's VEON position peaked at $6.33M in Q2 2017.
  • 117 funds tracked by Wall St. Rank held VEON as of Q2 2019.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.